Skip to main content
. 2020 Nov 16;7:590975. doi: 10.3389/fcvm.2020.590975

Figure 2.

Figure 2

All-cause mortality of TAVR vs. SAVR in low-intermediate surgical risk patients at 30 days, 1 year, and 2 years.